The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat
Authors:
- P.J GoadsbyPGP.J Goadsby
- 1 July 2001
- journal article
- Published by Elsevier in Brain Research
- Vol. 907 (1-2) , 117-124
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Glutamatergic transmission in the trigeminal nucleus assessed with local blood flowBrain Research, 2000
- Differential effects of low dose CP122,288 and eletriptan on Fos expression due to stimulation of the superior sagittal sinus in cat ☆Pain, 1999
- Pharmacological aspects of experimental headache models in relation to acute antimigraine therapyEuropean Journal of Pharmacology, 1999
- Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responsesCephalalgia, 1998
- Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pigBrain Research, 1997
- The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cordGeneral Pharmacology: The Vascular System, 1997
- Co-agonism in drug-receptor interaction: illustrated by the NMDA receptorsTrends in Pharmacological Sciences, 1996
- The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the ratPain, 1996
- The contribution of NMDA receptor activation to spinal c‐Fos expression in a model of inflammatory painBritish Journal of Pharmacology, 1995
- Rat tooth pulp projections to spinal trigeminal subnucleus caudalis are glutamate‐like immunoreactiveJournal of Comparative Neurology, 1991